💉 What if vaccines were stickers?
U. of Tokyo built a microneedle patch delivering COVID vaccines through skin — painless, no fridge, self-applied.
Mouse trials: 1.2x better immune response than needles.
170 years of syringes may end.
#MicroneedlePatch #VaccineTech

China Vaccine Technologies Market Size, Growth, Report 2035 China Vaccine Technologies Market is reaching at a CAGR of 11.61 %, Expected to Grow from USD 3.79 Billion to USD 12.70 Billion During 2025 - 2035.

🇨🇳💉 China Vaccine Technologies Market outlook 👉 www.marketresearchfuture.com/reports/chin... #VaccineTech #ChinaHealthcare #Biopharma

#Nature #Science #News #AI #Technology #ArtificialIntelligence #Healthcare #FutureofWork #Academia #HigherEducation #EdTech #CancerResearch #VaccineTech #ScienceNews #Innovation #DeepLearning #MachineLearning #Research

Healthcare Cold Chain Logistics Market Size, Share Forecast 2032 | MRFR Healthcare Cold Chain Logistics Market is projected to register a CAGR of 4.6% to reach USD 7.66 billion by the end of 2032, Global Healthcare Cold Chain Logistics Market Type, Application | Healthcar...

❄️ Keeping healthcare cool! Cold chain logistics innovations ensure safe transport of vaccines & medicines globally. #HealthcareLogistics #ColdChain #VaccineTech #MedTech

www.marketresearchfuture.com/reports/heal...

Larry Ellison’s Ellison Institute of Technology has just pledged £118 million to Oxford University to supercharge AI-powered research into vaccines that can target antibiotic-resistant pathogens.

Let’s see how AI rewrites the future of medicine.

#AIforHealth #VaccineTech #FutureOfMedicine #AI

6/13 mRNA's revolutionary speed advantage: Traditional flu vaccines take 5-6 months using hen's eggs. mRNA vaccines can produce millions of doses in just 6 weeks - crucial for pandemic response.
#VaccineTech #PandemicPrep

New mRNA Vaccine Promises Broader Immunity at Lower Cost A new mRNA vaccine developed by Pitt and Penn State researchers could offer long-lasting, broad-spectrum protection against fast-evolving viruses — at a fraction of the cost.

A new mRNA vaccine approach may end the race against viral mutations — and cut global vaccine costs. #vaccinetech #mRNA #infectiousdiseases